SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-15-007586
Filing Date
2015-02-11
Accepted
2015-02-10 18:47:17
Documents
1
Group Members
DAVID L. DOUGLASSDEEPIKA R. PAKIANATHAN, PH.D.DELPHI BIOINVESTMENTS VII, L.P.DELPHI MANAGEMENT PARTNERS VII, L.L.C.DOUGLAS A. ROEDERJAMES J. BOCHNOWSKI

Document Format Files

Seq Description Document Type Size
1 SC 13G v400799_sc13g.htm SC 13G 133902
  Complete submission text file 0001144204-15-007586.txt   135613
Mailing Address 3000 SAND HILL RD BUILDING 1 SUITE 135 MENLO PARK CA 94025
Business Address 3000 SAND HILL RD BUILDING 1 SUITE 135 MENLO PARK CA 94025 650-854-9650
DELPHI VENTURES VII L P (Filed by) CIK: 0001336922 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Subject) CIK: 0001423824 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88142 | Film No.: 15595581
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences